Abstract
The administration of pyridoxine-alpha-ketoglutarate (PAK) to type I and II diabetics previously treated with insulin and phenformin, reduces blood glucose, HbA1, and blood levels of lactate and pyruvate. The results of this double-blind clinical trial showed that PAK is advantageous for improving certain metabolic aspects in diabetics.
| Original language | English |
|---|---|
| Pages (from-to) | 252-256 |
| Number of pages | 5 |
| Journal | International Journal of Clinical Pharmacology Therapy and Toxicology |
| Volume | 21 |
| Issue number | 5 |
| Publication status | Published - 1983 |
Fingerprint
ASJC Scopus subject areas
- Toxicology
- Pharmacology (medical)
Cite this
Passariello, N., Fici, F., Giugliano, D., Ceriello, A., Dello Russo, P., & Sgambato, S. (1983). Effects of pyridoxine alpha-ketoglutarate on blood glucose and lactate in type I and II diabetics. International Journal of Clinical Pharmacology Therapy and Toxicology, 21(5), 252-256.